Edinburgh BioQuarter offers first-stop access to the unique combination of pre-clinical and clinical excellence in the Edinburgh Region. Edinburgh has the second largest concentration of researchers rated "internationally excellent" by the UK government, with a great quality of life and cost of living that's 20 percent lower than London.
Working with Scotland's extensive life sciences and health research networks, more than 870 commercial clinical trials have been undertaken across Scotland in the last three years.
Scotland is the only country to offer pharmaceutical companies access to a fully phenotyped population of more than 5.1 million individuals with electronic patient records linked by a single system, making it a location of choice for trials and pre-clinical research.
The wide range of capabilities concentrated on the BioQuarter campus makes it a leading European destination for translational medical research. Over the next five years the existing research community of 1,200 scientists at BioQuarter will be joined by the Edinburgh Sick Kids' Hospital (2015) and the Scottish Mind and Body (Neurology) centre in 2016.
Nine, The BioQuarter, home to one of Europe's highest quality concentrations of scientific talent, opened for business in March 2012. This 10,000 square metre bio-incubator building offers accommodation for academic, commercial and healthcare activity.
Vist the Edinburgh BioQuarter website for more information